Patent · US Active

Inhibitors of hepatitis C virus

US10603318B2 · kind B2 · utility

0Cited by
29References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2019
Grant dateMar 31, 2020
Priority date—
Expiry dateMay 10, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are disclosedAs well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.